Adjuvant therapy in type 1 diabetes mellitus - choice or necessity in the COVID-19 pandemic?

Cichocka, Edyta

Cichocka, Edyta.

Cichocka E; Department of Internal Medicine, Diabetology, and Nephrology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland. ecichocka@sum.edu.pl.

Endokrynol Pol ; 72(2): 89-90, 2021.

Article in English | MEDLINE | ID: covidwho-1222281

Subject(s)

COVID-19/therapy; Diabetes Mellitus, Type 1/therapy; Telemedicine/organization & administration; COVID-19/epidemiology; Diabetes Mellitus, Type 1/epidemiology; Disease Management; Glycemic Control; Health Behavior; Humans

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Telemedicine / Diabetes Mellitus, Type 1 / COVID-19 Type of study: Observational study Limits: Humans Language: English Journal: Endokrynol Pol Year: 2021 Document Type: Article Affiliation country: EP.a2021.0022

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google